Quest Partners LLC Krystal Biotech, Inc. Transaction History
Quest Partners LLC
- $1.02 Trillion
- Q2 2025
A detailed history of Quest Partners LLC transactions in Krystal Biotech, Inc. stock. As of the latest transaction made, Quest Partners LLC holds 579 shares of KRYS stock, worth $83,155. This represents 0.01% of its overall portfolio holdings.
Number of Shares
579
Previous 1,663
65.18%
Holding current value
$83,155
Previous $300 Million
73.46%
% of portfolio
0.01%
Previous 0.03%
Shares
6 transactions
Others Institutions Holding KRYS
# of Institutions
314Shares Held
24MCall Options Held
358KPut Options Held
441K-
Black Rock Inc. New York, NY3.95MShares$567 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.82MShares$405 Million0.01% of portfolio
-
Avoro Capital Advisors LLC New York, NY2.66MShares$382 Million6.67% of portfolio
-
State Street Corp Boston, MA1.36MShares$195 Million0.01% of portfolio
-
Capital World Investors Los Angeles, CA942KShares$135 Million0.02% of portfolio
About Krystal Biotech, Inc.
- Ticker KRYS
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 25,664,300
- Market Cap $3.69B
- Description
- Krystal Biotech, Inc., a clinical stage biotechnology company, engages in the field of redosable gene therapy to treat serious rare diseases in the United States. Its lead product candidate is beremagene geperpavec (B-VEC), which is in Phase III clinical study to treat dystrophic epidermolysis bullosa. The company is also involved in developing ...